Redsense Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Pontus Nobreus
Chief executive officer
kr745.0k
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 1.8yrs |
CEO ownership | n/a |
Management average tenure | 3yrs |
Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -kr8m |
Dec 31 2023 | n/a | n/a | -kr5m |
Sep 30 2023 | n/a | n/a | -kr6m |
Jun 30 2023 | n/a | n/a | -kr8m |
Mar 31 2023 | n/a | n/a | -kr7m |
Dec 31 2022 | kr745k | kr745k | -kr9m |
Compensation vs Market: Pontus's total compensation ($USD70.79K) is below average for companies of similar size in the German market ($USD396.66K).
Compensation vs Earnings: Insufficient data to compare Pontus's compensation with company performance.
CEO
Pontus Nobreus (59 yo)
1.8yrs
Tenure
kr745,000
Compensation
Mr. Pontus Nobreus serves as Chief Executive Officer of Redsense Medical AB (publ) since August 01, 2022. Mr. Nobreus served as Chief Executive Officer at Glycorex Transplantation AB (publ) since October 1...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 1.8yrs | kr745.00k | no data | |
Chief Financial Officer | 1.2yrs | no data | no data | |
Chief Operating Officer | 8.3yrs | no data | no data | |
Chief Technology Officer | 4.3yrs | no data | no data |
3.0yrs
Average Tenure
Experienced Management: R0Z's management team is considered experienced (3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Director | 11.3yrs | kr75.00k | no data | |
Chairman | less than a year | no data | no data | |
Director | 1.3yrs | no data | no data | |
Director | 1.3yrs | no data | no data |
1.3yrs
Average Tenure
53yo
Average Age
Experienced Board: R0Z's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.